Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head
VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated prim...
Gespeichert in:
Veröffentlicht in: | Clinical orthopaedics and related research 2009-12, Vol.467 (12), p.3273-3282 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3282 |
---|---|
container_issue | 12 |
container_start_page | 3273 |
container_title | Clinical orthopaedics and related research |
container_volume | 467 |
creator | Varoga, Deike Drescher, Wolf Pufe, Melanie Groth, Godo Pufe, Thomas |
description | VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head. |
doi_str_mv | 10.1007/s11999-009-1076-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2772917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2027497541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS1U1C6FH8ClsnoP2J7ETi6VUNndIlXqBareLNcZd11l48V2Cv33ONpVCwdO1vi9-WZGj5CPnH3ijKnPifOu6yrGuoozJSt4Qxa8EW3FOYgjsmCz0gl-d0LepfRYSqgbcUxOeKckKFEvyPNX7xxGHLM3A13-3kVMyYeRBkdvTbLTYCJdjn3IGxxmyzqGX3lDV8bmEKkf6XqYbLAhZm-D76uIg8nY05uUMYxoY0g-zbQCoCvchlggV2j69-StM0PCD4f3lPxYLb9fXlXXN-tvl1-uK9tAnSuOToKQpoam5a10WDMhGCiUwrie9bKVDYfWGdYgd0YBChBgHdryKdg9nJKLPXc33W-xt-XUsoLeRb818VkH4_W_yug3-iE8aaGU6LgqgPMDIIafE6asH8MUx7KzFgCyqUGKYuJ703xwiuheBnCm57D0PixdItFzWBpKz9nfm712HNIpBrE3pCKNDxhfJ_-f-geWmaJB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>233654362</pqid></control><display><type>article</type><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</creator><creatorcontrib>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</creatorcontrib><description>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</description><identifier>ISSN: 0009-921X</identifier><identifier>EISSN: 1528-1132</identifier><identifier>DOI: 10.1007/s11999-009-1076-3</identifier><identifier>PMID: 19763724</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Adult ; Cells, Cultured ; Conservative Orthopedics ; Dexamethasone - adverse effects ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Femur Head - blood supply ; Femur Head - drug effects ; Femur Head - metabolism ; Femur Head - pathology ; Femur Head Necrosis - chemically induced ; Femur Head Necrosis - metabolism ; Femur Head Necrosis - pathology ; Femur Head Necrosis - physiopathology ; Glucocorticoids - adverse effects ; Humans ; Immunohistochemistry ; Medicine ; Medicine & Public Health ; Middle Aged ; Neovascularization, Physiologic - drug effects ; Orthopedics ; Osteoarthritis, Hip - metabolism ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Osteoblasts - pathology ; Osteocytes - drug effects ; Osteocytes - metabolism ; Osteocytes - pathology ; Reverse Transcriptase Polymerase Chain Reaction ; Severity of Illness Index ; Sports Medicine ; Surgery ; Surgical Orthopedics ; Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors ; Time Factors ; Up-Regulation ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Clinical orthopaedics and related research, 2009-12, Vol.467 (12), p.3273-3282</ispartof><rights>The Association of Bone and Joint Surgeons® 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</citedby><cites>FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772917/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772917/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,41488,42557,51319,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19763724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varoga, Deike</creatorcontrib><creatorcontrib>Drescher, Wolf</creatorcontrib><creatorcontrib>Pufe, Melanie</creatorcontrib><creatorcontrib>Groth, Godo</creatorcontrib><creatorcontrib>Pufe, Thomas</creatorcontrib><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><addtitle>Clin Orthop Relat Res</addtitle><description>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</description><subject>Adult</subject><subject>Cells, Cultured</subject><subject>Conservative Orthopedics</subject><subject>Dexamethasone - adverse effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Femur Head - blood supply</subject><subject>Femur Head - drug effects</subject><subject>Femur Head - metabolism</subject><subject>Femur Head - pathology</subject><subject>Femur Head Necrosis - chemically induced</subject><subject>Femur Head Necrosis - metabolism</subject><subject>Femur Head Necrosis - pathology</subject><subject>Femur Head Necrosis - physiopathology</subject><subject>Glucocorticoids - adverse effects</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Orthopedics</subject><subject>Osteoarthritis, Hip - metabolism</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Osteoblasts - pathology</subject><subject>Osteocytes - drug effects</subject><subject>Osteocytes - metabolism</subject><subject>Osteocytes - pathology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Severity of Illness Index</subject><subject>Sports Medicine</subject><subject>Surgery</subject><subject>Surgical Orthopedics</subject><subject>Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors</subject><subject>Time Factors</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0009-921X</issn><issn>1528-1132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kUFv1DAQhS1U1C6FH8ClsnoP2J7ETi6VUNndIlXqBareLNcZd11l48V2Cv33ONpVCwdO1vi9-WZGj5CPnH3ijKnPifOu6yrGuoozJSt4Qxa8EW3FOYgjsmCz0gl-d0LepfRYSqgbcUxOeKckKFEvyPNX7xxGHLM3A13-3kVMyYeRBkdvTbLTYCJdjn3IGxxmyzqGX3lDV8bmEKkf6XqYbLAhZm-D76uIg8nY05uUMYxoY0g-zbQCoCvchlggV2j69-StM0PCD4f3lPxYLb9fXlXXN-tvl1-uK9tAnSuOToKQpoam5a10WDMhGCiUwrie9bKVDYfWGdYgd0YBChBgHdryKdg9nJKLPXc33W-xt-XUsoLeRb818VkH4_W_yug3-iE8aaGU6LgqgPMDIIafE6asH8MUx7KzFgCyqUGKYuJ703xwiuheBnCm57D0PixdItFzWBpKz9nfm712HNIpBrE3pCKNDxhfJ_-f-geWmaJB</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Varoga, Deike</creator><creator>Drescher, Wolf</creator><creator>Pufe, Melanie</creator><creator>Groth, Godo</creator><creator>Pufe, Thomas</creator><general>Springer-Verlag</general><general>Lippincott Williams & Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20091201</creationdate><title>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</title><author>Varoga, Deike ; Drescher, Wolf ; Pufe, Melanie ; Groth, Godo ; Pufe, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-1ef6326a4358186fe4022037e62afd0d6865138fa05e1fa73e2323cfec38f20b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Cells, Cultured</topic><topic>Conservative Orthopedics</topic><topic>Dexamethasone - adverse effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Femur Head - blood supply</topic><topic>Femur Head - drug effects</topic><topic>Femur Head - metabolism</topic><topic>Femur Head - pathology</topic><topic>Femur Head Necrosis - chemically induced</topic><topic>Femur Head Necrosis - metabolism</topic><topic>Femur Head Necrosis - pathology</topic><topic>Femur Head Necrosis - physiopathology</topic><topic>Glucocorticoids - adverse effects</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Orthopedics</topic><topic>Osteoarthritis, Hip - metabolism</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Osteoblasts - pathology</topic><topic>Osteocytes - drug effects</topic><topic>Osteocytes - metabolism</topic><topic>Osteocytes - pathology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Severity of Illness Index</topic><topic>Sports Medicine</topic><topic>Surgery</topic><topic>Surgical Orthopedics</topic><topic>Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors</topic><topic>Time Factors</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varoga, Deike</creatorcontrib><creatorcontrib>Drescher, Wolf</creatorcontrib><creatorcontrib>Pufe, Melanie</creatorcontrib><creatorcontrib>Groth, Godo</creatorcontrib><creatorcontrib>Pufe, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varoga, Deike</au><au>Drescher, Wolf</au><au>Pufe, Melanie</au><au>Groth, Godo</au><au>Pufe, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head</atitle><jtitle>Clinical orthopaedics and related research</jtitle><stitle>Clin Orthop Relat Res</stitle><addtitle>Clin Orthop Relat Res</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>467</volume><issue>12</issue><spage>3273</spage><epage>3282</epage><pages>3273-3282</pages><issn>0009-921X</issn><eissn>1528-1132</eissn><abstract>VEGF plays a role in bone remodeling. Ingrowth of reparative arterioles can be observed in late-stage osteonecrosis. To explore the reparative processes, we quantified the most important angiogenesis factor (VEGF) in different zones of late-stage glucocorticoid-induced osteonecrosis. We treated primary nonosteonecrosis osteoblasts with glucocorticoids in vitro as a model for the bone cells in early-stage steroid-related osteonecrosis. We obtained six late-stage (ARCO Stage IV) osteonecrosis femoral heads and six osteoarthritic femoral heads during THA. The expression of vascular endothelial growth factor was analyzed by reverse-transcription PCR, ELISA, or immunohistochemistry. Osteoblasts from the reactive interface (penumbra) of osteonecrosis femoral heads exhibited increased immunoreactivity to VEGF compared to those from the periphery. ELISA confirmed VEGF upregulation in the penumbra from osteonecrosis femoral heads. Primary osteoblasts derived from osteoarthritic femoral heads exhibited downregulation of VEGF after 24 hours of coincubation with glucocorticoids. The increase in VEGF in the reactive interface (penumbra) of osteonecrosis in late-stage femoral head may reflect a secondary phenomenon. The observed high amount of VEGF in later-stage osteonecrosis might stimulate the ingrowth of reparative arterioles into the femoral head.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>19763724</pmid><doi>10.1007/s11999-009-1076-3</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-921X |
ispartof | Clinical orthopaedics and related research, 2009-12, Vol.467 (12), p.3273-3282 |
issn | 0009-921X 1528-1132 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2772917 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | Adult Cells, Cultured Conservative Orthopedics Dexamethasone - adverse effects Dose-Response Relationship, Drug Enzyme-Linked Immunosorbent Assay Femur Head - blood supply Femur Head - drug effects Femur Head - metabolism Femur Head - pathology Femur Head Necrosis - chemically induced Femur Head Necrosis - metabolism Femur Head Necrosis - pathology Femur Head Necrosis - physiopathology Glucocorticoids - adverse effects Humans Immunohistochemistry Medicine Medicine & Public Health Middle Aged Neovascularization, Physiologic - drug effects Orthopedics Osteoarthritis, Hip - metabolism Osteoblasts - drug effects Osteoblasts - metabolism Osteoblasts - pathology Osteocytes - drug effects Osteocytes - metabolism Osteocytes - pathology Reverse Transcriptase Polymerase Chain Reaction Severity of Illness Index Sports Medicine Surgery Surgical Orthopedics Symposium: Tribute to Dr. Marshall Urist: Musculoskeletal Growth Factors Time Factors Up-Regulation Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - metabolism |
title | Differential Expression of Vascular Endothelial Growth Factor in Glucocorticoid-related Osteonecrosis of the Femoral Head |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A16%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20Expression%20of%20Vascular%20Endothelial%20Growth%20Factor%20in%20Glucocorticoid-related%20Osteonecrosis%20of%20the%20Femoral%20Head&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=Varoga,%20Deike&rft.date=2009-12-01&rft.volume=467&rft.issue=12&rft.spage=3273&rft.epage=3282&rft.pages=3273-3282&rft.issn=0009-921X&rft.eissn=1528-1132&rft_id=info:doi/10.1007/s11999-009-1076-3&rft_dat=%3Cproquest_pubme%3E2027497541%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=233654362&rft_id=info:pmid/19763724&rfr_iscdi=true |